oncology

J&J's Blue Jacket Fashion Show returns live to boost prostate cancer awareness
Fierce Pharma
Tue, 02/15/22 - 10:29 am
pharma marketing
JNJ
Janssen
oncology
prostate cancer
No regrets as Lyell prepares for its first clinical trial
EP Vantage
Mon, 02/7/22 - 11:13 am
Lyell Immunopharma
IPOs
clinical trials
cell therapy
cancer
oncology
Gilead's $4.9B oncology bet hit with partial clinical hold, forcing pause of pivotal trials and raising doubts about CD47
Fierce Biotech
Wed, 01/26/22 - 11:12 am
Gilead Sciences
magrolimab
anti-CD47
FDA
clinical trials
oncology
clinical hold
Cancer therapies lead way as FDA tallies 60 drug approvals in 2021
MedCity News
Sun, 01/2/22 - 11:31 pm
FDA
drug approvals
cancer
oncology
Sanofi buys US immuno-oncology biotech Amunix for $1 billion
Pharmaforum
Tue, 12/21/21 - 10:36 am
Sanofi
M&A
Amunix
immuno-oncology
cancer
solid tumors
oncology
Startup Mythic Therapeutics emerges with $103M to control fate of ADC cancer drugs
MedCity News
Thu, 12/16/21 - 12:02 pm
Mythic Therapeutics
antibody-drug conjugate
startups
cancer
lung cancer
oncology
Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control® Platform
PR Newswire
Mon, 12/13/21 - 10:51 am
Eli Lilly
Foghorn Therapeutics
oncology
Gerngross biotech Ankyra Therapeutics nabs $45M series B to jump into the clinic, hires new CMO
Fierce Biotech
Sun, 11/14/21 - 10:44 pm
Ankyra Therapeutics
funding
oncology
ANK-101
AbbVie, University of Chicago extend oncology research collaboration
Pharmaceutical Business Review
Sat, 11/13/21 - 09:52 pm
AbbVie
University of Chicago
R&D
oncology
AstraZeneca wields ax, scrapping midphase programs from $1B takeover, Heptares pact in latest quarterly cull
Fierce Biotech
Fri, 11/12/21 - 10:41 am
AstraZeneca
Ardea Biosciences
Zuraampic
oncology
diabetes
With oncology spinoff done, bluebird bio moves to new digs better suited to its future
Fierce Pharma
Sun, 11/7/21 - 10:50 pm
Bluebird Bio
oncology
Cambridge
Bluebird bio completes spinout of oncology business 2seventy bio
Bizjournals
Fri, 11/5/21 - 12:00 am
Bluebird Bio
spinoff
oncology
2seventy bio
Why did FDA ask Amgen to add low-dose trial of Lumakras?
Korea Biomed
Wed, 11/3/21 - 10:47 am
FDA
Amgen
clinical trials
Lumakras
oncology
cancer
Pillar Biosciences seeks to make precision medicine a first-line therapy for cancer patients
MedCity News
Tue, 11/2/21 - 11:47 pm
Pillar Biosciences
oncology
precision medicine
diagnostics
Signet Therapeutics gets a $10M top-up for next-gen cancer bets
Fierce Biotech
Fri, 10/29/21 - 11:07 am
Signet Therapeutics
funding
venture capital
China
cancer
oncology
bluebird bio provides update on 2seventy bio spin-off
PM Live
Tue, 10/12/21 - 11:49 pm
Bluebird Bio
2seventy bio
spinoff
oncology
Pfizer, Bayer-backed Pyxis ups IPO price as biotech's public run continues unabated
Fierce Biotech
Fri, 10/8/21 - 10:39 am
IPOs
Pyxis Oncology
Pfizer
Bayer
oncology
Trio of Biopharmas Generates Over $500 Million for AI, Oncology Innovation
BioSpace
Mon, 10/4/21 - 10:34 am
funding
artificial intelligence
oncology
TrialSpark
CBMG Holdings
Exscientia
Is the cancer immunotherapy market up for disruption as AstraZeneca, Regeneron-Sanofi, cheaper Chinese offerings line up?
Fierce Pharma
Sun, 10/3/21 - 08:27 pm
cancer
oncology
cancer immunotherapy
Merck
AstraZeneca
Regeneron
Sanofi
GSK's $4.2B bet on Merck KGaA's cancer drug goes up in smoke as pharmas cut ties after series of flops
Fierce Biotech
Thu, 09/30/21 - 10:58 pm
GSK
Merck KGaA
oncology
cancer
biliary tract cancer

Pages